Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just an observation: there are thirteen 1000 lot bid/asks on Level 2 hiding in plain sight. There’s usually only this many pre-market.
Hope so. Having some big fish slowly buying and holding in the coming days will definitely pay off down the road.
And way more shares being bid than being offered. 71 cents should hold.
Chicago is CMT.
Nevermind
I wonder if that gentleman, Adam Hayden, is a DCVax-L patient from 2016 on the first panel.
Okay, but only one exclamation point is the correct usage. Just kidding.
I recall someone who didn't like my capitalization of the proper noun "Best Actor Award", which was grammatically correct but too formal for a post on a forum. You can please some of the people some of the time... :)
Also from a Google search: "In American English, the management is used as a singular collective noun (like group) as American corpus and Ngram searches repeatedly confirm. A singular verb in order to maintain subject-verb agreement: The management gets its ideas from its employees. However, it is noteworthy that the COED (Concise Oxford English Dictionary) allows for the word to be regarded as plural: [treated as singular or plural] the people managing a company or organization, regarded collectively: Management were extremely cooperative." Like I said, experts disagree, but Crash didn't deserve to be corrected on this one.
https://english.stackexchange.com/questions/46609/is-the-word-management-singular-or-plural.
The most important thing is that management executes on the DCVax platform being approved. GL.
While expert grammarians have been known to disagree, in American English (vs. British English), these types of collective nouns (management, staff, class, group, committee, etc.) can be singular or plural based on the context of whether individuals are being referred to or the group as a whole.
Just to add, it’s my understanding that it’s not always easy to convert a traditional IRA to a Roth. For example, if someone had $2 million in a traditional Self-directed IRA and wanted to convert it to a Roth, they’d likely have to come up with the 35% income tax, or $700,000, in order to do it.
It is very possible that the aggregate combination treatments' initial retail costs and resulting high cure rates may be less costly than SOC primary and recurrent chemo/rad, surgery, and hospitalization charges.
I liked this part: “ An official with the U.S. Securities and Exchange Commission told Reuters on Wednesday the agency was "not currently contemplating" a short-selling ban.”
If this isn’t our DCVax and trial fails, the headlines will probably land on the front page of The Washington Post.
I think that confirms what you predicted all along.
That’s some fancy algorithm.
Any comments on the implications re: https://www.biopharmadive.com/news/roche-vabysmo-eylea-amd-sales-first-quarter/648679/
People with wet age-related macular degeneration must take frequent eye injections of biologic drugs like Lucentis and Eylea to slow the vision loss they experience. Drugmakers have sought to reduce the frequency of those injections to help patients as well as ophthalmologists seeking to free up staff and office resources. Meanwhile, insurers — primarily Medicare in the U.S. — have been looking to reduce the costs of paying for physician services.
The Food and Drug Administration recommends injecting Lucentis once a month, although patients can go with less frequent appointments if they’re willing to sacrifice some efficacy. Eylea, on the other hand, has similar effectiveness when taken every eight weeks after an initial dosing period of once every four weeks.
Vabysmo reduced dosing even further, to once every four months. Its annual list price of $6,570 during that maintenance phase, or $2,190 a shot, is competitive with Lucentis biosimilars, which cost around $1,000 a shot. Eylea biosimilars are expected to enter sometime this year or next.
Vabysmo’s strong launch puts pressure on Regeneron, which relies on Eylea for a bulk of its sales. But Regeneron aims to soon win U.S. approval of a high-dose version that could blunt competition.
Analysts at RBC Capital Markets expect Vabsymo’s market share to grow, but wrote in a note to clients that “the window of opportunity for Vabysmo to make significant competitive inroads to Eylea franchise may be narrowing” with the high-dose Eylea formulation coming.
NWBO-related, a move in the right direction: FINRA is being Petitioned in the Supreme Court of New York for allowing Stock Spoofing, Naked Shorting, and Market Manipulation
FINRA is being Petitioned in the Supreme Court of New York for allowing Stock Spoofing, Naked Shorting, and Market Manipulation pic.twitter.com/4zY0NyCjgK
— Meta News🚨 (@MMATNEWS) April 27, 2023
Amazing efficacy so far. I can’t remember the answer to this question: When this clinical trial is completed, does another one have to be done where NWBO is the sponsor, even though UCLA’s DC Vaccine is the same as NWBO’s DCVax? By the way, I sent my first email to DI with the question, “Has NWBO already submitted potions of the MA to MHRA in a rolling review?”
Grasping at straws, but I don't see any 1000-share lots on the pre-market bids this morning.
The KPS Score and hazard ratio pages don't have to be ignored in order to conclude that the MHRA should and will approve DCVax-L this year after all the data is considered.
You mean like ignoring the data in the JAMA Oncology article?
I struggle with worrying less these days compared to my youth, but I often fall short. That’s what I like about the whole forgiveness in Christ thing.
:) More virtue signaling from yours truly: Don’t worry about anything; instead, pray about everything. Tell God what you need, and thank him for all he has done. Then you will experience God’s peace, which exceeds anything we can understand. His peace will guard your hearts and minds as you live in Christ Jesus. Philippians 4:6-7
My understanding is that MMTLP trading was not only halted but it never resumed due to a merger, and the ticker was for preferred shares. I can’t imagine that scenario playing out for NWBO.
The likely drop in share price is due to a delayed MAA submission coupled with continued shorting and spoofing IMO. On the bright side, I recall a post from awhile back that identified precipitous drops in share prices being common for biotech startups prior to sustained breakouts.
Replied to the wrong post.
This may be indirectly related to NWBO: Title - Gary Gensler Expected to Answer Inquiries on MMTLP.
Securities and Exchange Commission (SEC) Chairman Gary Gensler is expected to answer inquiries on MMTLP during a hearing on Tuesday, April 18th.
Investors have gotten in touch with several government representatives and told their stories relating to the MMTLP scandal.
Earlier this month we found out Congress was getting involved in the MMTLP scandal through a leaked letter sent out to Meta Materials CEO
George Palikaras; however, a new letter from Congress details an ongoing investigation into naked short selling and other market fraud.
Congressman Bill Posey said in a letter that he’s been hearing from a variety of constituents on retail’s concerns involving MMTLP.
“While we have yet to be given evidence that anyone acted unlawfully or unscrupulously in this matter, I believe the regulatory agencies have an obligation to investigate this matter,” said the Congressman.
But evidence has indeed surfaced.
Conversations between FINRA and the SEC confirm the regulators knew of the fraud that was occurring in ticker symbol MMTLP.
Now investors are confirming they’ve been in contact with Congressman Warren Davidson, who has apparently confirmed to them SEC Chairman Gary Gensler will be questioned about MMTLP in front of the House Financial Services Committee.
A lot has happened since the U3 halt of ticker symbol MMTLP.
FINRA has responded to investors, though no solutions have been provided.
And now congress is investigating the fraud with investors expecting Gary Gensler to answer questions about MMTLP in the upcoming hearing.
Here are just but a few questions investors are inquiring about the events:
Is the SEC aware of the U3 halt and investigation by FINRA into the listing, trading and halting of MMTLP?
Has the SEC seen the blue sheets on MMAT and MMTLP, and if so, why doesn’t the public have these numbers?
Has the SEC investigated any of the short sellers or market makers who were short on MMTLP after the merger between Torch and MMTLP?
Relating to the OCC, has the SEC investigated their role and lack of oversight?
Is the SEC aware of any communications FINRA had with market participants and FINRA reps on the MMTLP situation since its inception to ending?
When you discover who the bad actors are, what punishment will they receive?
John Brda says that there are two distinctive ways to resolve the MMTLP situation.
Is to allow two days of trading under strict supervision.
And the second is to get the ‘bad actors’ to solve their settlement problems by buying shares of Next Bridge Hydrocarbons.
“You really have two ways to resolve the situation. You can basically allow for two days of trading under supervision so that there’s no funny business going on; there’s no additional shorting, there’s no buying from retail, it’s only position close only.
And there would be short covering only in that situation. But that cannot be under the ticker symbol MMTLP. The only way that could happen is with FINRA’s involvement and Next Bridge’s involvement as well to allow it to happen.
And again, for two days only, give people the two day that they missed and see where the chips fall; we’ll see what happens in that situation.”
“The only other scenario would be for, again after finding out all the information via blue sheets and share counts and information/questions we ask FINRA, how bad the situation is and who is involved, is that those actors can come to Next Bridge, try to solve their problem by buying shares from Next Bridge Hydrocarbons and settling out their issues that way.
We’ll see where it goes – I believe those are the only two solutions and hopefully we’ll get to a solution here shortly.”
SEC Chairman Gary Gensler has been known to doge questions regarding manipulation and regulatory accountability very well.
Hearing him answer questions about the MMTLP scandal will be quite interesting to hear.
https://franknez.com/gary-gensler-expected-to-answer-inquiries-on-mmtlp/
Anyone, would an injunction prohibit the defendants from just spoofing or trading NWBO shares entirely?
I may be mistaken, but I thought the injunction would prohibit them from not just spoofing but trading NWBO shares entirely.
I thought the same, that the defendants wouldn’t be changing how they trade the stock, at least in the near-term for fear that it would signal their guilt. As pqr stated, the request for an injunction is not preliminary, so if the defendants were forced to cease trading in the long-term, the subsequent pps increase could be explained away due to approval(s). Ex replied to a post of mine awhile back regarding your point about liquidity with a maybe or maybe not opinion. I would think after these seven MMs were removed, there would be plenty of others remaining to pick up the slack. However, I’m far from a SME on how all this works. I was wondering if a judge could implement a preliminary injunction even if one wasn’t requested.
From info. gathered on Twitter, I believe the Time Magazine cover is fake, but the story behind it isn't.
He’s also on the board at Regeneron Pharmaceuticals, Inc., and they attended the NWBO TLD presentation at NYAS last year. Small world. ;)
Already posted. Please remove.
If the current pps is .605, then a spoof at .615 would have to be on the bid, not an ask, right?
It's been reported that ChatGPT is flat out wrong on many occasions. This is just one more example to add to the list.
HL, you may not believe in conspiracy theories, but individuals and organizations conspire all the time. Mountains of evidence are in history books and court transcripts.
I’m not a mind-reader, but I think he was only kidding about coming to a conclusion based on Thermo’s cautious remark.